Clinical Trial Update: Lipid Efficacy Study (0524B-022)(COMPLETED) [Phase 3]

View source ↗

Summary

A Phase 3 lipid efficacy trial sponsored by Merck Sharp & Dohme LLC has completed (Study 0524B-022) for primary hypercholesterolemia and mixed hyperlipidemia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypercholesterolemia
• Mixed Hyperlipidemia

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Primary Hypercholesterolemia, Mixed Hyperlipidemia | Phase 3 | Status: COMPLETED